期刊文献+

端粒和端粒酶在癌症中的研究进展及意义 被引量:12

The Significance and Progress of Telomere and Telomerase in Cancer
下载PDF
导出
摘要 端粒是位于染色体末端的DNA串联重复序列,对基因组稳定性和完整性起保护作用。端粒的长度与细胞周期密切相关。其长度变化机制分为依赖端粒酶活性和端粒重组两类,氧化应激和铅(Pb)与端粒酶的功能蛋白相结合抑制其活性,致使端粒缩短,硒(Se)与二者具有拮抗作用,延缓衰老。相关数据表明85%肿瘤细胞与端粒酶活性成正相关,以端粒酶活性作为肿瘤治疗靶标称为当代热点之一。主要对肺癌、乳腺癌等恶性肿瘤与端粒的相关性进行了综述,以期为端粒和端粒酶在癌症治疗研究提供参考依据。 Telomeres is DNA tandem repeats the ends of linear chromosomes, and telomere stability was required for genome stability. The length of the telomeres was closely associated with the cell cycle. Its length change mechanism was divided into dependent on telomerase activity and telomere restructuring. Evidence have shown that oxidative stress can alter the structure and function of telomere. Its activity was inhibited when plumbum combined with telomerase, then telomeres were shortened. But selenium have antagonism effect with both, which made senility to delay. Relevant data showed that 85% of tumor cells with telomerase activity were positive correlation. Telomerase activity is an essential characteristic of cancer cells, which known as one of the cancer targets. Lung cancer, breast cancer and other malignant tumor correlated with telomeres were reviewed. It may provide references for the study of telomere and telomerase in cancer therapy.
出处 《生命科学研究》 CAS CSCD 北大核心 2014年第3期260-264,共5页 Life Science Research
基金 中央高校科研专项基金项目资助(11NZYTH03)
关键词 端粒 端粒酶 肿瘤 telomere telomerase tumor
  • 相关文献

参考文献33

  • 1CUI W, WYLIE D, ASLAM S, et ol. Telomerase-immortalized sheep fibroblasts can be reprogrammed by nuclear transfer to undergo early development[J]. Biology of Reproduction, 2003, 69 (1): 15-21.
  • 2ROYLEN N J, BERMUDEZA M, GRAVANI A, et al. Role of recombination in telomere length maintenance[J]. Biochemical Society Transctions, 2009, 37(Pt3): 589-595.
  • 3MARSH T C, VESENKA J, HENDERSON E. A new DNA nano-structure, the G-wire, imaged by scanning probe mi- croscopy[J]. Nucleic Acids Research, 1995, 23(4): 696-700.
  • 4MARTINEZ P, BLASCO M A. Telomeric and extra-telomeric roles for telomerase and the telomere-binding proteins[J]. Na- ture Reviews Cancer, 2011, 11 (3): 161-176.
  • 5NGUYENB N, EMOREL W. Mechanism of dominant negative telomerase funotion[J]. Cell Cycle, 2009, 8(19):3227-3233.
  • 6ZAKIAN V A. Telomeres beginning to understand the end[J]. Science, 1995, 270(5242): 1601-1607.
  • 7BAZAROV A V, HINES W C, MUKHOPADHYAY R, et al. Telomerase activationby cMyc in human mammary epithelial cells requires additional genomic changes[J]. Cell Cycle, 2009, 8(20): 3373-3378.
  • 8WICK M, ZUBOV D, HAGEN G. Genomic organization and promoter eharaeterization of the gene encoding the human tle- ormerase reverse transeriptase(hTERT)[J]. Gene, 1999, 232(1):97-106.
  • 9DE L T. Shekterin: the protein complex that shapes and safe- guards human telomeres[J]. Genes & Development, 2005, 19(18): 2100-2110.
  • 10BIANCHI A, STANSEL R M, FAIRALL L, et ol. TRF1 binds a bipartite telomeric site with extreme spatial flexibility [J]. The EMBO Journal, 1999, 18(20): 5735-5744.

二级参考文献62

  • 1曹娟,郑杰,吕秀宁.维生素C增强As_2O_3诱导宫颈癌HeLa细胞凋亡的研究[J].东南大学学报(医学版),2005,24(5):294-299. 被引量:3
  • 2张士侠,李心,尹家乐,陈莉莉,张洪泉.江苏地产白首乌C_(21)甾苷抗衰老作用研究[J].实用老年医学,2007,21(2):104-107. 被引量:11
  • 3JU Z Y,RUDOLPH L.Telomerc Dysfunction and Stem Cell Ageing[J].Biochimie,2008,90:24-32.
  • 4KUMAKURA S I,TSUTSUI T W,YAGISAWA J,et al.Reversible Conversion of Immortal Human Cells from TelomerasePositive to Telomerase-Negative ceu8[J].Cancer Res,2005,65(7):2778-2786.
  • 5LIU L,BAILEY S M,OKUKA M,et al.Telomerc Lengthening Early in Development[J].Nature Cell Biology,2007,12(9):1426-1441.
  • 6THIBAUD J,CHUNG I,HEUVELMAN G,et al.Dynamics of Telomeros and Promyelocytic Leukemia Nuclear Bodies in a Telomerase-negative Human Cell Line[J].Molecular Biology of the Cell,2009,20:2070-2082.
  • 7ZENG S C,XIANGT,PANDITATK,et al.Telomere Recombination Requires the MUSSI Endonuclease[J].Nature Cell Biology,2009,5(11):616-23.
  • 8GONZALO S,JACO I,FRAGA M F,et al.DNA Methyltransferases Control Telomere Length and Telomere Recombination in Mammalian Cells[J].Nature Cell Biol,2006,8:416-424.
  • 9ZHOU D,LIU T,ZHOU X,et al.Three Key Variables Involved in Feeder Preparation for the Maintenance of Human Embryonic Stem Cells[J].Cell Biol Int,2009,33(7):796-800.
  • 10Ye J, Lenain C, Bauwens S, et al. TRF2 and apollo cooperate with to- poisomerase 2 alpha to protect human telomeres from replicative damage [J]. Cell, 2010, 142 (2): 230.

共引文献19

同被引文献98

引证文献12

二级引证文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部